Back to companies
IRulya Therapeutics Inc.
IRLAUSNASDAQPharmaceuticals & HealthcareIRulya Therapeutics Inc.
Revenue
—
FY2025
Operating income
-$58.1mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API